Clinical Report: CMRA-DETR: An Efficient and Precise Framework for Identifying Brain Tumors in MRI Scans
Overview
The CMRA-DETR framework demonstrates high accuracy in identifying brain tumors in MRI scans, achieving a precision of 95.5% and a recall of 95.7%. Its architectural innovations significantly enhance detection capabilities while reducing computational demands.
Background
Accurate identification of brain tumors in MRI scans is crucial for effective treatment planning and patient outcomes. Traditional methods face challenges due to low contrast and irregular tumor shapes, necessitating advanced automated detection frameworks. The development of CMRA-DETR addresses these challenges, potentially improving diagnostic accuracy in clinical settings.
Data Highlights
Metric
Value
Precision
95.5%
Recall
95.7%
mAP@50
97.9%
mAP@50-95
82.6%
Parameter Reduction
37.7%
GFLOPs Reduction
30.9%
Key Findings
CMRA-DETR achieves a precision of 95.5% and recall of 95.7% on an internal test dataset.
The framework records a mAP@50 of 97.9% and mAP@50-95 of 82.6%.
It reduces parameters and GFLOPs by 37.7% and 30.9%, respectively, compared to baseline models.
On an external test set from the BRISC dataset, it achieves mAP@50 of 96.6% without fine-tuning.
CMRA-DETR utilizes a CSP-MambaOut backbone for improved local texture recognition.
The model incorporates a RetBlockC3 module for enhanced spatial continuity modeling of irregular tumors.
Clinical Implications
The CMRA-DETR framework offers a promising tool for enhancing the accuracy of brain tumor detection in MRI scans, which could lead to improved patient management and treatment outcomes. Its efficiency makes it suitable for deployment in resource-limited clinical settings.
Conclusion
CMRA-DETR represents a significant advancement in automated brain tumor detection, combining high accuracy with reduced computational requirements, thereby facilitating its practical application in clinical environments.
